Live Breaking News & Updates on Translational Molecular
Stay updated with breaking news from Translational molecular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nanoparticles for optimized cancer therapy miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
KIT - KIT - Media - Press Releases - PI 2023 - Nanoparticles for optimized cancer therapy kit.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kit.edu Daily Mail and Mail on Sunday newspapers.
MD Anderson Launches Oncology Data Science Institute to Battle Cancer miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
TransCode Therapeutics and MD Anderson Announce Strategic Alliance to Advance RNA Therapies for Oncology wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
Single-cell map offers a new immunotherapy target for lung cancer treatment Researchers at The University of Texas MD Anderson Cancer Center have developed a first-of-its-kind spatial atlas of early-stage lung cancer and surrounding normal lung tissue at single-cell resolution, providing a valuable resource for studying tumor development and identifying new therapeutic targets. The study was published today in Cancer Discovery, a journal of the American Association for Cancer Research. The findings reveal a heterogeneous lung cancer ecosystem, with extensive interactions between cancer cells and the surrounding microenvironment that regulate early cancer development. By studying the crosstalk between the tumor and surrounding immune cells, researchers identified and validated CD24, an immune checkpoint protein, as a new immunotherapy target for lung cancer treatment. ....